PhD-Programme: Applications

We offer an international research environment, characterized by outstanding ageing research, excellent supervision, early independence in research and state-of-the-art facilities. We are dedicated to providing first-class conditions for young scientists in a cutting edge and inspiring environment. Our competitive PhD programme provides a world-class starting platform for a successful career in science.

The programme is highly selective and invites outstanding university graduates wishing to work towards a PhD in the fields of ageing and age-related diseases to become part of the vibrant and international research scene in the Cologne/Bonn area.


Our international and interdisciplinary faculty offers positions in the areas of cell or molecular biology, biochemistry, biophysics, bioinformatics, bioengineering, pharmacology, neuroscience medical biology, translated medicine or related fields. We invite applicants with a Master's or equivalent degree of the above mentioned or related fields. Applicants with a degree in medicine are equally welcome to apply provided they have sufficient relevant research experience. Furthermore, candidates require excellent written and spoken English skills (C1 level).

Selection procedure

Candidates are selected based on their academic qualifications, research accomplishments and motivation. Up to 30 candidates will be invited to our recruitment week in March 2022, which will be held online. Admitted candidates will be offered individual visits to our partner institutes and host labs after the recruitment week. A PhD position can be started between July and October 2022. All accepted students will be enrolled through the University of Cologne.

Please check our FAQ for further information:

Application period

The application call for PhD projects starting between July and October 2022 is closed now. Our next call will open in August 2022. Further information about our program can be found in our FAQs.


Application period 2022

The online application platform is now closed.